MetLife, Inc. (MET) Trigger Multiple Signals Fast

On the technicals front, MetLife, Inc. (NYSE:MET) overall has 40% Buy rating. The stock is also flashing a Buy from the Barchart TrendSpotter trading system. Traders hoping to speculate on the MET’s short-term trajectory should know that short terms indicators for the stock averaged 20% Buy with an average daily trading volume over the past 20 days at 5031300 shares. MET stock has overall a 0.75% Buy signal considering medium term indicators and the 50-day average daily volume remained almost 6642164 shares. It’s also worth noting that the stock, whose average daily volume over the 100 days prior to this writing was 6724345 shares, is 0% Hold on the basis of long term indicators.

The share price is currently staying around the first support level of $44.95. Below this, the next support is placed in the zone of $44.7. Till the time, the MET stock trades above this level, bulls have nothing to fear. On momentum oscillators front, ‘RSI’ has touched 59.29 on daily chart, which may remain a cause for concern. If the price breaks below $44.7 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $45.36 mark may result into a pull-back move towards $45.52 level.

MetLife, Inc. (MET) is projected to climb by 12.28 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $63 price as 12-month high target. This represents a whopping 39.38 percent increase from where shares are trading today. The 12-month median price target assigned by the analysts stands at $51, which represents a return potential of 12.83 percent when compared to the closing price of the stock of $45.2 on Tuesday, February 05. The lowest price target for the stock is $37 — slightly more than -18.14 percent from MET’s current share price.

Here’s a rundown of insider trading activity for sense of MetLife, Inc. (NYSE:MET). The earliest insider trade took place on 12/17/2018. Gutierrez Carlos M gathered a total of 6.4 thousand shares of company at average share price of $39.04. The total for the purchase was set at $249.86 thousand. After this transaction, the Director account balance stood at 23.48 thousand shares. The stock grew 15.78 percent since that insider purchase. On 08/27/2018, Kandarian Steven A, Chairman, President & CEO, sold 42.81 thousand shares at a price per share of $47.03. This removed 2.01 million shares from the insider’s fortune and the stock saw a -3.89 percent retreat in value since the news became public. This transaction left 525.54 thousand shares in the Chairman, President & CEO account. On 08/21/2018, Chairman, President & CEO Kandarian Steven A performed a sale transaction worth $4.02 million. This sale at $46.93 each has eliminated 85.68 thousand shares from the insider’s portfolio position. Meanwhile, shares have recorded -3.69 percent decrease since the transaction was reported. The insider now is left with 508.57 thousand shares remaining in the account. Hassell Gerald L, who performs the Director job, bought 10 thousand shares for $461.8 thousand. The acquisition occurred on 05/09/2018 was priced at $46.18 per share. The share price plunged -2.12 percent since the reporting date. Hassell Gerald L now left with a stake of 11.05 thousand MET stock worth $499.32 thousand after the insider buying.

MET shares accumulated 0.04 points or 0.09 percent on Tuesday to $45.2 with a light trade volume of 4.025 million shares. After opening the session at $45.18, the shares went as high as $45.27 and as low as $44.86, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $44.2 billion and now has 977.07 million shares outstanding. MetLife, Inc. (MET) stock has gained 6.91 percent of market value in 21 trading days.

Analysts at BofA/Merrill upped their rating on shares of MetLife, Inc. (NYSE:MET) from Neutral to Buy in their opinion released on January 16. Sandler O’Neill analysts bumped their recommendation on MET stock from Hold to Buy in a separate flash note to investors on January 02. Analysts at Goldman downgraded the stock to a Neutral call from its previous Buy stance, in a research note that dated back to June 04.

MET stock has a trailing 3-year beta of 1.19, offering the possibility of a higher rate of return, but also posing more risk. The portion of a company’s profit allocated to each outstanding share of common stock was $4.82 a share in the trailing twelve months. The stock’s value has surged 10.08 percent year to date (YTD) against a decline of -4.96 percent in 12 month’s time. The company’s shares still trade -7.6 percent away from its 1-year high of $48.92 and 19.7 percent up from 52-week low of $37.76. The average consensus rating on the company is 2.3, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a sell.

Shares of MetLife, Inc. (MET) are trading at a P/E ratio of 9.14 times earnings reported for the past 12 months. The industry MET operates in has an average P/E of 13.42. Its P/E ratio went as low as 8.9X and as high as 16.53 over the 5-year span. Further, it is sporting a 0.65 on the Price-to-Sales ratio. Compare this with the industry average P/S of 1.01. 0 percent is the gross profit margin for MetLife, Inc. and operating margin sits at 8.8 percent. Along with this, the net profit margin is 7.8 percent.

MET will be declaring its Q4 financial results on February 06. Analysts are forecasting revenue to climb 3.4 percent to $15.9B in the next fiscal quarter, while earnings are seen soaring by nearly 101.56 percent to $1.29 per share. History has shown that shares in MetLife, Inc. have gone down on 20 different earnings reaction days and are predicted to add 0.02 percent when the company reports upcoming earnings. In last reported earnings results, it earned $1.38 per share, better than the $1.27, adjusted, expected by Thomson Reuters consensus estimate. Revenue was $16.4B, better than the $16.1B analysts expected. Earnings are estimated to increase by 35.7 percent this year, 3.05 percent next year and continue to increase by 16.69 percent annually for the next 5 years.